title: Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.
abstract: OBJECTIVE
  To evaluate ursodeoxycholic acid (UDCA) therapy on the in vitro contraction of gallbladder smooth muscle strips from cholesterol gallstone patients.
  
  
  METHODS
  The contraction forces of gallbladder smooth muscle strips from 28 patients with cholesterol gallstones treated with UDCA were compared with contraction forces from 14 untreated patients. The strips were stimulated with increasing concentrations of cholecystokinin-8 (CCK-8).
  
  
  RESULTS
  Although the contraction forces that developed in response to CCK-8 were higher in strips from specimens of UDCA treated patients compared to untreated patients, longer treatment periods (6-wk) caused more contraction responses than the short treatment period of 3-wk (F = 19.297, 1.85 +/- 0.22 g vs 1.70 +/- 0.10 g, P < 0.01). Contraction forces developed with maximal stimulation with KCl in the 6-wk treatment group were also higher than contraction forces in the untreated group (F = 4.274, 3.77 +/- 0.45 g vs 3.30 +/- 0.30 g, P < 0.05).
  
  
  CONCLUSIONS
  Six-week UDCA treatment caused an increase in contractions of muscle strips from patients with cholesterol gallstones when compared to shorter treatment administration or controls. We suggest that extending UDCA treatment periods may cause more effective contractions in the gallbladder, and thereby increase the rate of response to treatment.
authors: Department of Internal Medicine, Gülhane School of Medicine, GATA Ic Hasta-liklari B.D., Etlik 06018 Ankara, Turkey.
authors: Mehmet-Refik
authors: MR
authors: Mas
authors: Bilgin
authors: B
authors: Comert
authors: Nuket
authors: N
authors: Mas
authors: Levent
authors: L
authors: Yamanel
authors: Haluk
authors: H
authors: Ozotuk
authors: Ilker
authors: I
authors: Tasci
authors: Riadh-P
authors: RP
authors: Jazrawi
mesh_terms: D000368:Aged; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002763:Cholecystectomy; D002784:Cholesterol; D004305:Dose-Response Relationship, Drug; D005704:Gallbladder / Q000187:drug effects / Q000503:physiopathology*; D042882:Gallstones / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects* / Q000502:physiology; D009130:Muscle, Smooth / Q000187:drug effects* / Q000503:physiopathology; D012844:Sincalide / Q000494:pharmacology; D013997:Time Factors; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid; D002784:Cholesterol; D012844:Sincalide
references: Neth J Med. 1987 Apr;30(3-4):160-71
references: 3600900
references: Gastroenterology. 1990 Dec;99(6):1779-85
references: 2227291
references: Gastroenterology. 1988 Sep;95(3):740-8
references: 3396819
references: Gastroenterology. 1984 Aug;87(2):299-307
references: 6329890
references: Schweiz Med Wochenschr. 1987 Aug 15;117(33):1217-20
references: 3672067
references: Gastroenterology. 1997 Sep;113(3):930-7
references: 9287986
references: Gastroenterology. 1989 Dec;97(6):1479-84
references: 2583414
references: Gastroenterology. 1990 Sep;99(3):836-42
references: 2199291
references: Am J Med. 2000 Apr 15;108(6):481-6
references: 10781781
references: Dig Dis Sci. 1999 Jan;44(1):190-6
references: 9952243
references: Hepatology. 2003 Jun;37(6):1442-50
references: 12774024